Materials & Resources » Chemicals | Yifan Pharmaceutical Co. Ltd.

Yifan Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own Yifan Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
5,548,578
0.78%
-5,188,319
2.67%
12/31/2017
Guotai Jinying Growth Securities Investment Fund
5,275,332
0.75%
5,275,332
1.69%
12/31/2017
4,632,743
0.66%
-2,685,490
4.98%
12/31/2017
3,100,006
0.44%
3,100,006
1.56%
12/31/2017
Nanfang High Growth Fund
3,000,000
0.42%
3,000,000
2.86%
12/31/2017
Bosera Services Sector Growth Fund
3,000,000
0.42%
3,000,000
2.33%
12/31/2017
Nanfang CSI 500 ETF
2,581,769
0.37%
-402,200
0.24%
12/31/2017
First State Cinda Leaders Growth Equity Fund
1,873,700
0.27%
-968,006
1.61%
12/31/2017
1,800,000
0.25%
1,800,000
1.72%
12/31/2017
1,608,946
0.23%
-999,118
0.66%
12/31/2017

About Yifan Pharmaceutical Co.

View Profile
Address
No. 50 Qinshan
Hangzhou Zhejiang 311300
China
Employees -
Website http://www.xinfupharm.com
Updated 07/08/2019
Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. It focuses on pharmaceutical products, raw materials, and polymer materials. The pharmaceutical products include antibiotics, cardiovascular and cerebrovascular, skin, gynecology, pediatric, blood tumor, and treatment of large infusion.